Onconova Therapeutics, a US-based anti-cancer drugs developer backed in India-based peer Cadila Healthcare, has raised $50m, according to a regulatory filing. News provider Philadelphia Business Journal reports that the developer raised $26.4m in a two-part raise earlier in the year. Investors currently represented on the Onconova’s board include Cadila Healthcare, and venture capital firms ICICI…
The rest of this content is only accessible to Global Venturing Subscribers.
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
